Wu YL - Search Results

1

Clinical trials for lung cancer in China.

Niu FY, Zhong WZ, Zhou Q, Wu YL. Niu FY, et al. Among authors: wu yl. Transl Lung Cancer Res. 2014 Oct;3(5):311-6. doi: 10.3978/j.issn.2218-6751.2014.10.04. Transl Lung Cancer Res. 2014. PMID: 25806317 Free PMC article. Review.

2

[The application of needle video-assisted thoracoscopic biopsy in pathologic diagnosis and staging for advanced lung cancer].

Gu LJ, Wu YL, Feng WN, Weng YM, Cheng C, Zhong WZ, Huang SH. Gu LJ, et al. Among authors: wu yl. Zhonghua Jie He He Hu Xi Za Zhi. 2003 Jul;26(7):396-9. Zhonghua Jie He He Hu Xi Za Zhi. 2003. PMID: 12921642 Chinese.

3

[Treatment of non-small-cell lung cancer with paraplatin given by two different dosage calculation methods].

Gu LJ, Wu YL, Feng WN, Weng YM, Cheng C, Zhong WZ, Huang SH, Yang P. Gu LJ, et al. Among authors: wu yl. Zhonghua Zhong Liu Za Zhi. 2005 Jan;27(1):29-32. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 15771794 Clinical Trial. Chinese.

4

[Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].

Cheng C, Wu YL, Gu LJ, Chen G, Weng YM, Feng WN, Zhong WZ. Cheng C, et al. Among authors: wu yl. Ai Zheng. 2005 Jul;24(7):846-9. Ai Zheng. 2005. PMID: 16004813 Clinical Trial. Chinese.

5

[Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis].

Qiao GB, Wu YL, Ou W, Yang XN, Zhong WZ, Lin JY, Zhao J, Xie D, Guan XY. Qiao GB, et al. Among authors: wu yl. Zhonghua Wai Ke Za Zhi. 2005 Jul 15;43(14):913-7. Zhonghua Wai Ke Za Zhi. 2005. PMID: 16083620 Chinese.

6

[Relationship of the curative effects of gefitinib on non-small cell lung carcinoma to gender and to epithelial growth factor receptor status].

Xu CR, Lin JY, Wang Z, Zhou Q, Zhang GC, Wang K, Yang XN, Chen G, Yang JJ, Huang YJ, Liao RQ, Wu YL. Xu CR, et al. Among authors: wu yl. Zhonghua Yi Xue Za Zhi. 2006 Oct 10;86(37):2606-10. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17198584 Chinese.

7

[Gefitinib target treatment in non-small cell lung cancer].

Wu YL, Yang JJ, Lin JY, Huang YJ, Liao RQ, Huang YS, Zhou Q, Xu CR, Wang Z. Wu YL, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2007 Feb;30(2):98-102. Zhonghua Jie He He Hu Xi Za Zhi. 2007. PMID: 17445469 Clinical Trial. Chinese.

8

Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland China.

Wu YL, Zhong WZ, Li LY, Zhang XT, Zhang L, Zhou CC, Liu W, Jiang B, Mu XL, Lin JY, Zhou Q, Xu CR, Wang Z, Zhang GC, Mok T. Wu YL, et al. J Thorac Oncol. 2007 May;2(5):430-9. doi: 10.1097/01.JTO.0000268677.87496.4c. J Thorac Oncol. 2007. PMID: 17473659 Free article.

9

Lung cancer management in the Asia-Pacific region: what's the difference compared with the United States and Europe? Results of the Second Asia Pacific Lung Cancer Conference.

Wu YL, Zhou Q. Wu YL, et al. J Thorac Oncol. 2007 Jun;2(6):574-6. doi: 10.1097/01.JTO.0000275341.39960.6c. J Thorac Oncol. 2007. PMID: 17545856 Free article. No abstract available.

10

[Association of XAGE-1b gene expression with clinical characteristics of non-small cell lung cancer].

Zhou Q, Guo AL, An SJ, Xu CR, Yang SQ, Wu YL. Zhou Q, et al. Among authors: wu yl. Nan Fang Yi Ke Da Xue Xue Bao. 2007 Jul;27(7):966-8. Nan Fang Yi Ke Da Xue Xue Bao. 2007. PMID: 17666327 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,366 results

Search Page

Filters